Preview

Национальный журнал Глаукома

Расширенный поиск

Роль витаминов группы В в предупреждении прогрессирования глаукомной оптической нейропатии

https://doi.org/10.53432/2078-4104-2021-20-3-87-101

Полный текст:

Аннотация

В литературном обзоре обсуждается роль витаминов (особенно витаминов группы В) в обеспечении нейропротекторной и антиоксидантной защиты сетчатки при глаукомной оптической нейропатии. Приводятся данные зарубежных исследований, посвященных изучению положительного влияния витаминов данной группы на состояние ганглиозных клеток сетчатки и аксонов зрительного нерва.

Об авторах

И. А. Лоскутов
ГБУЗ МО МОНИКИ им. М.Ф. Владимирского
Россия

 д.м.н., заведующий отделением офтальмологии 

  129110,  Москва, ул. Щепкина, д. 61/2 



А. В. Корнеева
АНО «Клиника микрохирургии глаза Взгляд»
Россия

 Корнеева Алина Владимировна,  к.м.н., врач-офтальмолог 

  117463,  Москва, Голубинская ул., 16 



Список литературы

1. Resnikoff S., Pascolini D., Etya'ale D., Kocur I. et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82(11):844–851. doi.org//S0042-96862004001100009

2. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3):262–267. doi.org/10.1136/bjo.2005.081224

3. Weinreb R.N., Aung T., Medeiros F.A. The pathophysiology and treatment of glaucoma: A review. JAMA. 2014; 311(18):1901–1911. doi:10.1001/jama.2014.3192

4. Heijl A., Bengtsson B., Chauhan B.C., Lieberman M.F. et al. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology. 2008; 115(9): 1557–1565. doi:10.1016/j. ophtha.2008.02.005

5. Gillespie B.W., Musch D.C., Guire K.E., Mills R.P., Lichter P.R., Janz N.K., Wren P.A.; CIGTS (Collaborative Initial Glaucoma Treatment Study) Study Group. The collaborative initial glaucoma treatment study: Baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci. 2003; 44(6):2613–2620. doi:10.1167/iovs.02-0543

6. Chauhan B.C., Mikelberg F.S., Balaszi A.G., LeBlanc R.P., Lesk M.R., Trope G.E.; Canadian Glaucoma Study Group. Canadian glaucoma study: risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008; 126(8):1030–1036. doi:10.1001/archopht.126.8.1030

7. Adatia F.A., Damji K.F. Chronic open-angle glaucoma. Review for primary care physicians. Can Fam Physician. 2005; 51(9):1229–1237.

8. Bagnis A., Papadia M., Scotto R., Traverso C.E. Current and emerging medical therapies in the treatment of glaucoma. Expert Opin Emerg Drugs. 2011; 16(2):293–307. doi:10.1517/14728214.2011.563733

9. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126(4):498–505. doi:10.1016/s0002-9394(98)00272-4

10. Heijl A., Leske M.C., Bengtsson B., Hyman L., Bengtsson B., Hussein M. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002; 120(10):1268–1279. doi:10.1001/archopht.120.10.1268

11. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002; 134(4):499–512. doi:10.1016/s0002-9394(02)01659-8

12. Morrone L.A., Rombola L., Adornetto A., Corasaniti M.T., Russo R. Rational basis for nutraceuticals in the treatment of glaucoma. Curr Neuropharmacol. 2017; 16(7):1004–1017. doi:10.2174/1570159X15666171109124520

13. Soto I., Howell G.R. The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med. 2014; 4(8): a017269. doi:10.1101/cshperspect.a017269

14. Križaj D., Ryskamp D.A., Tian N., Tezel G., Mitchell C.H., Slepak V.Z., Shestopalov V.I. From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma. Curr Eye Res. 2014; 39(2):105–119. doi:10.3109/02713683.2013.836541

15. Yuan L., Neufeld A.H. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia. 2000; 32(1):42–50.

16. Stringham J.M., Snodderly D.M. Enhancing performance while avoiding damage: a contribution of macular pigment. Invest Opthalmol Vis Sci. 2013; 54(9):6298–6306. doi:10.1167/iovs.13-12365

17. Coleman A.L., Stone K.L., Kodjebacheva G., Yu F., Pedula K.L., Ensrud K.E., Cauley J.A., Hochberg M.C., Topouzis F., Badala F., Mangione C.M.; Study of Osteoporotic Fractures Research Group.Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol. 2008; 145(6):1081–1089. doi:10.1016/j.ajo.2008.01.022

18. Kang J.H., Pasquale L.R., Willett W.C., Rosner B.A., Egan K.M., Faberowski N., Hankinson S.E. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr. 2004; 79(5):755–764.тdoi:10.1093/ajcn/79.5.755

19. Ramdas W.D., Wolfs R.C., Kiefte-de Jong J.C., Hofman A., de Jong P.T., Vingerling J.R., Jansonius N.M. Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study. Eur J Epidemiol. 2012; 27(5):385–393. doi:10.1007/s10654-012-9672-z

20. Renard J.P., Rouland J.F., Bron A., Sellem E., Nordmann J.P., Baudouin C., Denis P., Villain M., Chaine G., Colin J., de Pouvourville G., Pinchinat S., Moore N., Estephan M., Delcourt C. Nutritional, lifestyle and environmental factors in ocular hypertension and primary openangle glaucoma: an exploratory case-control study. Acta Ophthalmol. 2013; 91(6):505–513. doi:10.1111/j.1755-3768.2011.02356.x

21. Wang S.Y., Singh K., Lin S.C. Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States. Eye (Lond). 2013; 27(4):487–494. doi:10.1038/eye.2013.10

22. Kang J.H., Pasquale L.R., Willett W., Rosner B., Egan K.M., Faberowski N., Hankinson S.E. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003; 158(4):337–346. doi:10.1093/aje/kwg167

23. Li S., Li D., Shao M., Cao W., Sun X. Lack of association between serum vitamin B6, vitamin B12, and vitamin D levels with different types of glaucoma: A systematic review and meta-analysis. Nutrients. 2017; 9(6):636. doi:10.3390/nu9060636

24. Izzotti A., Saccà S.C., Cartiglia C., De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med. 2003; 114(8):638–646. doi:10.1016/s0002-9343(03)00114-1

25. Saccà S.C., Pascotto A., Camicione P., Capris P., Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol. 2005; 123(4):458–463. doi:10.1001/archopht.123.4.458

26. Ganapathy P.S., White R.E., Ha Y., Bozard B.R., et al. The role of N-methyl-Daspartate receptor activation in homocysteine-induced death of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2011; 52(8):5515–5524. doi:10.1167/iovs.10-6870

27. Engin K.N. Alpha-tocopherol: looking beyond an antioxidant. Mol Vis. 2009; 15:855–860.

28. Ritch R. Neuroprotection: Is it already applicable to glaucoma therapy? Curr Opin Ophthalmol. 2000; 11(2):78–84. doi:10.1097/00055735-200004000-00002

29. Himori N., Kunikata H., Shiga Y., Omodaka K., Maruyama K., Takahashi H., Nakazawa T. The association between systemic oxidative stress and ocular blood flow in patients with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2016; 254(2):333–341. doi:10.1007/s00417-015-3203-z

30. Mares J.A. High-dose antioxidant supplementation and cataract risk. Nutr Rev. 2004; 62(1):28–32. doi:10.1111/j.1753-4887.2004.tb00003.x

31. Evans J. Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond). 2008; 22(6):751–760. doi:10.1038/eye.2008.100

32. Asregadoo E.R. Blood levels of thiamine and ascorbic acid in chronic open-angle glaucoma. Ann Ophthalmol. 1979; 11(7): 1095–1100.

33. Giaconi J.A., Yu F., Stone K.L., Pedula K.L., Ensrud K.E., Cauley J.A., Hochberg M.C., Coleman A.L.; Study of Osteoporotic Fractures Research Group. The association of consumption of fruits/vegetables with decreased risk of glaucoma among older African-American women in the study of osteoporotic fractures. Am J Ophthalmol. 2012; 154(4):635–644. doi:10.1016/j.ajo.2012.03.048

34. Jung K.I., Kim Y.C., Park C.K. Dietary niacin and open-angle glaucoma: the korean national health and nutrition examination survey. Nutrients. 2018; 10(4):387. doi:10.3390/nu10040387

35. Williams P.A., Harder J.M., Foxworth N.E., Cochran K.E., Philip V.M., Porciatti V., Smithies O., John S.W. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017; 355(6326):756–760. doi:10.1126/science.aal0092

36. Cui X., Chopp M., Zacharek A., Roberts C., Buller B., Ion M., Chen J. Niacin treatment of stroke increases synaptic plasticity and axon growth in rats. Stroke. 2010; 41:2044–2049. doi:10.1161/STROKEAHA.110.589333

37. Kaplon R.E., Gano L.B., Seals D.R. Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults. J Appl Physiol (1985). 2014; 116(2):156–163. doi:10.1152/japplphysiol.00969.2013

38. Graff E.C., Fang H., Wanders D., Judd R.L. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metabolism. 2016; 65(2):102–113. doi:10.1016/j.metabol.2015.10.001

39. Kerr J.S., Adriaanse B.A., Greig N.H., Mattson M.P., Cader M.Z., Bohr V.A., Fang E.F. Mitophagy and Alzheimer's disease: cellular and molecular mechanisms. Trends Neurosci. 2017; 40(3):151–166. doi:10.1016/j.tins.2017.01.002

40. Liu D., Pitta M., Jiang H., Lee J.H., Zhang G., Chen X., Kawamoto E.M., Mattson M.P. Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol Aging. 2013; 34(6):1564–1580. doi:10.1016/j.neurobiolaging.2012.11.020

41. Wang X., Hu X., Yang Y., Takata T., Sakurai T. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Brain Res. 2016; 1643:1–9. doi:10.1016/j.brainres.2016.04.060

42. Gasperi V., Sibilano M., Savini I., Catani M.V. Niacin in the central nervous system: an update of biological aspects and clinical applications. Int J Mol Sci. 2019; 20(4):974. doi:10.3390/ijms20040974

43. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994; 38:S3–S6. doi:10.1016/0039-6257(94)90041-8

44. Drance S., Anderson D.R., Schulzer M.; Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001; 131(6):699–708. doi:10.1016/s0002-9394(01)00964-3

45. Henry E., Newby D.E., Webb D.J., O’Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999; 40(8): 1710–1714.

46. Buckley C., Hadoke P.W., Henry E., O’Brien C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br J Ophthalmol. 2002; 86(2): 227–232. doi:10.1136/bjo.86.2.227

47. Ebadi M. Regulation and function of pyridoxal phosphate in CNS. Neurochem Int. 1981; 3(3–4):181–205. doi:10.1016/0197-0186(81)90001-2

48. Miller N.R., Newman N.J. Walsh & Hoyt’s Clinical Neuro-Ophthalmology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 1997.

49. Albert D.M., Jakobiec F.A., Azar D.T., Gragoudas E.S. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia, W. B. Saunders Company; 2000. doi:org/10.1016/S0039-6257(00)00166-1

50. Sugiyama T. Coexisting normal-tension glaucoma and deficiencies of folic acid and vitamin B6 (Pyridoxal). Int J Ophthalmol Clin Res. 2015; 2:5. doi:10.23937/2378-346X/1410037

51. Chisholm I.A. Serum cobalamin and folate in the optic neuropathy associated with tobacco smoking. Can J Ophthalmol. 1978; 13:105–109.

52. Knox D.L., Chen M.F., Guilarte T.R., Dang C.V., Bumette J. Nutritional amblyopia: folic acid, vitamin B12, and other vitamins. Retina. 1982; 2(4):288–293.

53. Golnik K.C., Schaible E.R. Folate-responsive optic neuropathy. J Neuroophtalmol. 1994; 14(3):163–169.

54. Hsu C.T., Miller N.R., Wray M.L. Optic neuropathy from folic acid deficiency without alcohol abuse. Opthalmologica. 2002; 216:65–67. doi:10.1159/000048300

55. de Silva P., Jayamanne G., Bolton R. Folic acid deficiency optic neuropathy: a case report. J Med Case Rep. 2008; 2:299. doi:10.1186/1752-1947-2-299

56. Kesler A., Pianka P. Toxic optic neuropathy. Curr Neurol Neurosci Rep. 2003; 3(5):410–414. doi:10.1007/s11910-003-0024-y

57. Santandrea E., Sani I., Morbioli G., Multari D., Marchini G., Chelazzi L. Optic nerve degeneration and reduced contrast sensitivity due to folic acid deficiency: a behavioral and electrophysiological study in rhesus monkeys. Invest Ophthalmol Vis Sci. 2018; 59(15):6045–6056.doi:10.1167/iovs.18-24822

58. McCully K.S. Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr. 2007; 86(5):1563S–1568S. doi:10.1093/ajcn/86.5.1563S

59. Roedl J.B., Bleich S., Reulbach U., von Ahse N., Schlötzer-Schrehardt U., Rejdak R., Naumann G.O.H., Kruse F.E., Kornhuber J., Jünemann A.G.M. Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma. J Neural Transm. 2007; 114(4):445–450. doi:10.1007/s00702-006-0556-9

60. Xu F., Zhang L., Li M. Plasma homocysteine, serum folic acid, serum vitamin B12, serum vitamin B6, MTHFR and risk of pseudoexfoliation glaucoma: A meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2012; 250(7):1067–1074. doi:10.1007/s00417-011-1877-4

61. Kang J.H., Loomis S.J., Wiggs J.L., Willett W.C., Pasquale L.R. A prospective study of folate, vitamin B6, and vitamin B12 intake in relation to exfoliation glaucoma or suspected exfoliation glaucoma. JAMA Ophthalmol. 2014; 132(5):549–559. doi:10.1001/jamaophthalmol.2014.100

62. Fenech M. Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity. Mutat Res. 2012; 733(1–2):21–33. doi:10.1016/j.mrfmmm.2011.11.003

63. Chan W., Almasieh M., Catrinescu M.M., Levin L.A. Cobalamin-associated superoxide scavenging in neuronal cells is a potential mechanism for vitamin b12-deprivation optic neuropathy. Am J Pathol. 2018; 188(1):160–172. doi:10.1016/j.ajpath.2017.08.032

64. Anand O.P., Choudhary S.K., Gupta S. Vitamin B12 deficiency induced optic neuropathy. Delhi J Ophthalmol. 2019; 29;125–126. doi:http://dx.doi.org/10.7869/djo.467

65. Larner A.J. Visual failure caused by vitamin B12 defciency optic neuropathy. Int J Clin Pract. 2004; 58(10):977–978. doi:10.1111/j.1368-5031.2004.00306.x

66. Chavala S.H., Kosmorsky G.S., Lee M.K., Lee M.S. Optic neuropathy in vitamin B12 defciency. Eur J Intern Med. 2005; 16(6):447–448. doi:10.1016/j.ejim.2005.01.021

67. Pineles S.L., Avery R.A., Liu G.T. Vitamin B12 optic neuropathy in autism. Pediatrics. 2010; 126(4):e967–970. doi:10.1542/peds.2009-2975

68. Chu C., Scanlon P. Vitamin B12 deficiency optic neuropathy detected by asymptomatic screening. BMJ Case Rep. 2011; 2011: bcr0220113823. doi:10.1136/bcr.02.2011.3823

69. Jalil A., Usmani H.A., Khan M.I., Blakely E.L., Taylor R.W., Vassallo G., Ashworth J. Bilateral paediatric optic neuropathy precipitated by vitamin B12 defciency and a novel mitochondrial DNA mutation. Int Ophthalmol. 2013; 33(6):687–690. doi:10.1007/s10792-013-9773-z

70. Sawicka-Pierko A., Obuchowska I., Hady R.H., Mariak Z., Dadan J. Nutritional optic neuropathy following bariatric surgery. Wideochir Inne Tech Maloinwazyjne. 2014; 9(4):662–666. doi:10.5114/wiitm.2014.47262

71. Wadia N.H., Desai M.M., Quadros E.V., Dastur D.K. Role of vegetarianism, smoking, and hydroxocobalamin in optic neuritis. Br Med J. 1972; 3:264–267.

72. Chester E.M., Agamanolis D.P., Harris J.W., Victor M., Hines J.D., Kark J.A. Optic atrophy in experimental vitamin B12 deficiency in monkeys. Acta Neurol Scand. 1980; 61(1):9–26. doi:10.1111/j.1600-0404.1980.tb02991.x

73. Sadun A.A. Metabolic optic neuropathies. Semin Ophthalmol. 2002; 17(1):29–32. doi:10.1076/soph.17.1.29.10290

74. Турушева А.В., Моисеева И.Е. Недостаточность питания в пожилом и старческом возрасте. Российский семейный врач. 2019;23(1):5–15. doi:10.17816/RFD201915-15

75. Iwakawa H., Nakamura Y., Fukui T., Fukuwatari T., Ugi S., Maegawa H., Doi Y., Shibata K. Concentrations of water-soluble vitamins in blood and urinary excretion in patients with diabetes mellitus. Nutr Metab Insights. 2016; 9:85–92. doi:10.4137/NMI.S40595

76. Larner A.J. Visual failure caused by vitamin B12 defi ciency optic neuropathy. Int J Clin Pract. 2004; 58(10):977–978. doi:10.1111/j.1368-5031.2004.00306.x

77. Türkyılmaz K., Öner V., Türkyılmaz A.K., Kırba¸s A., Kırba¸s S., ¸Sekeryapan B. Evaluation of peripapillary retinal nerve fiber layer thickness in patients with vitamin B12 deficiency using spectral domain optical coherence tomography. Curr Eye Res. 2013; 38(6):680–684. doi:10.3109/02713683.2012.758291

78. Earnest C.P., Wood K.A., Church T.S. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation. J Am Coll Nutr. 2003; 22(5):400–407. doi:10.1080/07315724.2003.10719323

79. Flynn M.A., Irvin W., Krause G. The effect of folate and cobalamin on osteoarthritic hands. J Am Coll Nutr. 1994; 13(4):351–356. doi:10.1080/07315724.1994.10718421

80. Greenberg S.S., Xie J., Zatarain J.M., Kapusta D.R., Miller M.J. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxininduced hypotension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther. 1995; 273(1):257–265. doi:10.1080/07315724.1994.10718421

81. Crocket J.A. Cyanocobalamin in asthma. Acta Allergol. 1957; 11(4):261–268. doi:10.1111/j.1398-9995.1957.tb03037.x

82. Miller J.W. Vitamin B12 deficiency, tumor necrosis factor-alpha, and epidermal growth factor: a novel function for vitamin B12? Nutr Rev. 2002; 60(5 Pt 1):142–144. doi:10.1301/00296640260093805

83. Volkov I., Rudoy I., Press Y. Successful treatment of chronic erythema nodosum with vitamin B12. J Am Board Fam Pract. 2005; 18(6):567–569. doi:10.3122/jabfm.18.6.567

84. Wheatley C. A scarlet pimpernel for the resolution of inflammation? The role of supratherapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Med Hypotheses. 2006; 67(1): 124–142. doi:10.1016/j.mehy.2006.01.036

85. Yamashiki M., Nishimura A., Kosaka Y. Effects of methylcobalamin (vitamin B12) on in vitro cytokine production of peripheral blood mononuclear cells. J Clin Lab Immunol. 1992; 37(4):173–182.

86. Bagli E., Goussia A., Moschos M.M., Agnantis N., Kitsos G. Natural compounds and neuroprotection: mechanisms of action and novel delivery systems. In Vivo. 2016; 30(5):535–547.

87. Vohra R., Tsai J.C., Kolko M. The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol. 2013; 58(4):311–320. doi:10.1016/j.survophthal.2012.08.010

88. Agudo M., Perez-Marin M.C., Sobrado-Calvo P., Lönngren U. et al. Immediate upregulation of proteins belonging to different branches of the apoptotic cascade in the retina after optic nerve transection and optic nerve crush. Invest Opthalmol Vis Sci. 2009; 50(1):424–431. doi:10.1167/iovs.08-2404

89. Chang E.E., Goldberg J.L. Glaucoma 2.0: Neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology. 2012; 119(5):979–986. doi:10.1016/j.ophtha.2011.11.003

90. Pescosolido N., Librando A. Oral administration of an association of forskolin, rutin and vitamins B1 and B2 potentiates the hypotonising effects of pharmacological treatments in POAG patients. Clin Ter. 2010; 161(3):e81-85.

91. Sisto D., Lavermicocca N., Errico D., Rusciano D. Oral administration of forskolin and rutin contributes to reduce intraocular pressure and improve PERG (pattern electroretinogram) amplitude in glaucomatous patients. JSM Biotechnol Biomed Eng. 2014; 2(1):1036.

92. Vetrugno M., Uva M.G., Russo V., Iester M., Ciancaglini M., Brusini P., Centofanti M., Rossetti L.M. Oral administration of forskolin and rutin contributes to intraocular pressure control in primary open-angle glaucoma patients under maximum tolerated medical therapy. J Ocul Pharmacol Ther. 2012; 28(5):536–541. doi:10.1089/jop.2012.0021

93. Mutolo M.G., Albanese G., Rusciano D., Pescosolido N. Oral administration of Forskolin, Homotaurine, Carnosine, and Folic Acid in patients with primary open angle glaucoma: changes in intraocular pressure, pattern electroretinogram amplitude, and foveal sensitivity. J Ocul Pharmacol Ther. 2016; 32(3):178–183. doi:10.1089/jop.2015.0121

94. Wan M.J., Daniel S., Kassam F., Mutti G., Butty Z., Kasner O., Trope G.E., Buys Y.M. Survey of complementary and alternative medicine use in glaucoma patients. J Glaucoma. 2010; 21(2):79–82. doi:10.1097/IJG.0b013e3182027c0c

95. Belmonte A., Tormo C., Lopez N., Villalba C., Fernandez C., Hernandez F. Vitamins A, E, B12 and folate levels in different types of glaucoma. Clin Chem Lab Med. 2011; 49:S816.

96. Lopez-Riquelme N., Villalba C., Tormo C., Belmonte A., Fernandez C., Torralba G., Hernandez F. Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients. Int Ophthalmol. 2015; 35(4): 527–532. doi:10.1007/s10792-014-9979-8

97. Cumurcu T., Sahin S., Aydin E. Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol.2006; 6:6. doi:10.1186/1471-2415-6-6

98. Xu F., Zhao X., Zeng S.-M., Li L., Zhong H.-B., Li M. Homocysteine, B vitamins, methylenetetrahydrofolate reductase gene, and risk of primary open-angle glaucoma: a meta-analysis. Ophthalmology. 2012; 119(12):2493–2499. doi:10.1016/j.ophtha.2012.06.025

99. Li J., Xu F., Zeng R., Gong H., Lan Y. Plasma homocysteine, serum folic acid, serum vitamin B12, serum vitamin B6, MTHFR, and risk of normal-tension glaucoma. J Glaucoma. 2016; 25:e94–e98. doi:10.1097/IJG.0000000000000269

100. Сui X., Xiang J., Zhu W., Wei A., Le Q., Xu J., Zhou X. Vitamin A palmitate and carbomer gel protects the conjunctiva of patients with long-term prostaglandin analogs application. J Glaucoma. 2016; 25(6):487–492. doi:10.1097/IJG.0000000000000316

101. Yuki K., Murat D., Kimura I., Ohtake Y., Tsubota K. Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2010; 248(2):243–248. doi:10.1007/s00417-009-1183-6

102. Ramdas W.D., Schouten J.S.A.G., Webers C.A.B. The effect of vitamins on glaucoma: a systematic review and meta-analysis. Nutrients. 2018; 10(3):359. doi:10.3390/nu10030359

103. Gye H.J., Kim J.M., Yoo C., Shim S.H., Won Y.S., Sung K.C., Lee M.Y., Park K.H. Relationship between high serum ferritin level and glaucoma in a South Korean population: The Kangbuk Samsung health study. Br J Ophthalmol. 2016; 100(12):1703–1707. doi:10.1136/bjophthalmol-2015-307678

104. Krefting E.A., Jorde R., Christoffersen T., Grimnes G. Vitamin D and intraocular pressure — results from a case-control and an intervention study. Acta Ophthalmol. 2014; 92(4):345–349. doi:10.1111/aos.12125

105. Engin K.N., Engin G., Kucuksahin H., Oncu M., Engin G., Guvener B. Clinical evaluation of the neuroprotective effect of alpha-tocopherol against glaucomatous damage. Eur J Ophthalmol. 2007; 17(4):528–533. doi:10.1177/112067210701700408

106. Saccà S.C., Gandolfi S., Bagnis A., Manni G., Damonte G., Traverso C.E., Izzotti A. The outflow pathway: a tissue with morphological and functional unity. J Cell Physiol. 2016; 231(9):1876–1893. doi:10.1002/jcp.25305


Рецензия

Для цитирования:


Лоскутов И.А., Корнеева А.В. Роль витаминов группы В в предупреждении прогрессирования глаукомной оптической нейропатии. Национальный журнал Глаукома. 2021;20(3):87-101. https://doi.org/10.53432/2078-4104-2021-20-3-87-101

For citation:


Loskoutov I.A., Korneeva A.V. The role of B vitamins in preventing the progression of glaucomatous optic neuropathy. National Journal glaucoma. 2021;20(3):87-101. (In Russ.) https://doi.org/10.53432/2078-4104-2021-20-3-87-101

Просмотров: 141


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2078-4104 (Print)
ISSN 2311-6862 (Online)